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Abstract
Introduction. Mycobacterium marinum is a non-tubercular mycobacterium residing in fresh or salt water (in tropical or
temperate areas); it is a fish and human pathogen, and in immunocompromised patients can cause severe cutaneous and
subcutaneous infections.
Case presentation. A 46-year-old white man who underwent immunosuppressive therapy was admitted to our department in
May 2016 for skin lesions previously diagnosed as ‘unusual erysipelas’. We rejected the hypothesis of erysipelas, due to the
clinical features, and our diagnostic hypotheses were oriented towards sporotrichosis, atypical mycobacteriosis, cutaneous
tuberculosis and cutaneous sarcoidosis. Histological examination performed after a skin biopsy was compatible with a
diagnosis of sporotrichosis. However, PCR performed on fresh tissue demonstrated the presence of M. marinum.
Conclusion. The case reported is interesting for the unusual clinical localization and modality of infection. The patient
became infected by contact with contaminated remains or in the sea, in a geographical area not endemic for M. marinum.
The previous state of immunosuppression favoured infection; however, the presence of M. marinum in this area suggests a
possible tropicalization of the water of the Mediterranean Sea. To our knowledge, this case is the only one reported in the
literature with this modality of infection and in that geographical area.
INTRODUCTION
Mycobacterium marinum is a non-tubercular mycobacte-
rium residing in fresh or salt water (in tropical or temperate
areas); it is a fish and human pathogen, and in immuno-
compromised patients can cause severe cutaneous and sub-
cutaneous infections [1]. Herein, we present a case of
unusual cutaneous infection caused by M. marinum.
CASE REPORT
A 46-year-old white man was admitted to our department in
May 2016 for skin lesions previously diagnosed as ‘unusual
erysipelas’. The patient was affected by hypogammaglobuli-
naemia and renal sarcoidosis, and previously underwent
immunosuppressive therapy based on tacrolimus and
monthly doses of intravenous immunoglobulin.
Dermatological examination revealed spread purplish papu-
lar-pustular lesions, tending to confluence at the back of the
left foot, and two ulcerating nodules with purplish and infil-
trated margins on the lower third of the left leg (Fig. 1). The
patient also presented a satellite nodule and lymphangitic
streak on the left thigh. The lesions occurred from Septem-
ber 2015 onwards.
Laboratory examinations gave normal results, with the
exception of a slight increase of C-reactive protein and a
skin swab positive for Staphylococcus aureus sensitive to
meticillin and Streptococcus anginosus. At the time of the
first visit, the patient had already been treated according to
antibiogram results with a partial improvement.
We rejected the hypothesis of erysipelas, due to the clinical
features, and considered the skin swab positivity as a possi-
ble contamination. Our diagnostic hypotheses were oriented
towards sporotrichosis, atypical mycobacteriosis, cutaneous
tuberculosis and cutaneous sarcoidosis.
Chest X-ray and ultrasound examination did not demon-
strate visceral involvement. Histological examination
performed after a skin biopsy revealed a pseudoepithelioma-
tous hyperplasia of the epidermis and a dermic granuloma-
tous inflammatory infiltrate with the formation of
epithelioid granulomas. These findings were compatible
with a diagnosis of sporotrichosis, but PAS staining was
negative. The pathologist also had used Ziehl–Neelsen
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staining with negative results. However, PCR performed on
fresh tissue demonstrated the presence of M. marinum. At
this point, deepening the medical history, the patient
remembered that in the summer of 2015 he had suffered an
abrasion under the left foot when walking on the beach in
Tuscany (Castiglione della Pescaia). The lesions occurred
some months after.
The patient was treated with clarithromycin, 500mg twice
daily, and rifampicin, 600mg once a day orally. After 6
months of therapy, we observed a full clinical, histologically
confirmed, remission of the cutaneous lesions. Only a few
pigmented, non-palpable lesions remained (Fig. 2).
DISCUSSION
M. marinum is a slow-growing (5–14 days) photochromo-
gens mycobacteria (group I of Runyon’s classification)
widely disseminated worldwide [1]. The incubation period
for the lesions caused by this bacterium is variable from
a week to months (8–60 days) [2]. The median time to
diagnosis is 3.5 months [3]. The annual incidence is esti-
mated at 0.27 cases per 100 000 persons in the USA [3], but
in the literature there is no data available for the incidence
in Italy.
The common presentation in immunocompetent patients is
generally related to jobs or hobbies with exposure to fresh
or salt water; indeed, the main form of inoculation is skin
trauma followed by exposure to the marine environment or
aquatic animals (fish, shell, aquariums) [1]. Thus, M. mari-
num infections are known as ‘fish-tank granuloma’, ‘aquar-
ium granuloma’ or ‘swimming pool granuloma’, although
the frequency of such manifestations is reduced due to the
chlorination of the water [1, 2]. The more frequently
affected anatomical sites are the hands, forearms and elbows
[2]. Initially, a solitary, violaceous papule or nodule at the
site of inoculation can progress to a verrucous plaque and/
or ulcer. Proximal extension may occur through lymphatic
spread and 20% of patients present with a sporotrichoid
distribution [1], particularly in immunosuppressed patients
who may have scattered and deep manifestations with septi-
caemia [4]. The main immunosuppressive conditions pre-
disposing to atypical mycobacteriosis are human
immunodeficiency virus infection, solid organ transplanta-
tion (incidence of 0.2–2.8% in heart, 0.5–8% in lung and
0.16–0.38% in kidney transplant patients [5]) and therapy
with TNF inhibitors (infliximab, adalimumab) [3, 6].
For the correct diagnosis, the following are important: a
careful medical history, physical and histological examina-
tion, and microbiological culture on fresh tissue from skin
biopsy. PCR on tissue or culture is very helpful to confirm
diagnosis [7].
The therapy varies depending on the severity of the lesions;
if the lesions are limited, they can resolve spontaneously or
with antibiotic monotherapy (clarithromycin, azithromy-
cin, moxifloxacin, tetracyclines and trimethoprim/sulfa-
methoxazole) [1]. Multidrug therapy is recommended for
more extensive infections with the involvement of deeper
structures or for severe infections with a sporotrichoid dis-
tribution pattern (clarithromycin associated with rifampi-
cin or ethambutol) [1, 6]. The treatment is prolonged,
taking between 6 weeks and 6 months (at least 2 months
after the clinical remission [6] and in deep infections taking
18 months [4, 8]). Surgical treatment is usually reserved for
cases of subcutaneous tissue (tendons or bone) involvement
[1].
The case reported is interesting for the unusual clinical
localization and modality of infection. The patient became
infected by contact with contaminated remains or in the
sea, in a geographical area not endemic for this bacterium.
The previous state of immunosuppression favoured infec-
tion; however, the presence of M. marinum in this area sug-
gests a possible tropicalization of the water of the
Fig. 1. Spread purplish papular-pustular lesions, tending to conflu-
ence at the back of the left foot, and two ulcerating nodules with pur-
plish and infiltrated margins on the lower third of the left leg.
Fig. 2. The patient’s foot after 6 months of therapy.
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Mediterranean Sea. To our knowledge, this case is the only
one reported in the literature with this modality of infection
and in that geographical area.
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